GlassScriptPhysician profile
Nima Khosravani
NPI 1326501784
$3,813.34
in general payments reported to CMS, 2019-2025
12 companies · $684 in 2025
The $684 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2022: $216 · 2023: $331 · 2024: $2,466 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740 · Education: $1,000 · Travel and Lodging: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.45 |
| Education | $1,000.00 |
| Travel and Lodging | $740.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,062.13 | 2024 | |
| Davol INC. | $335.24 | 2025 | |
| Medtronic, INC. | $312.46 | 2023 | Interstim, Endurant Iis |
| Vertex Pharmaceuticals Incorporated | $264.57 | 2025 | |
| Stryker Corporation | $216.13 | 2022 | |
| Kerecis Limited | $156.82 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Becton, Dickinson and Company | $127.78 | 2024 | Phasix Mesh |
| Surmodics, INC. | $118.99 | 2024 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy System |
| Merck Sharp & Dohme LLC | $97.22 | 2019 | |
| Integra Lifesciences Corporation | $84.49 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Shire North American Group INC | $18.90 | 2019 | |
| Convatec INC. | $18.61 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nima Khosravani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.